Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

This content is available also in other languages


This content is available also in other languages

June 24, 2009 | Customer News

Catching up on crime














The Missouri State Highway Patrol Laboratory in Jefferson City has recently installed a Freedom EVO® liquid handling workstation from Tecan to automate all the steps of DNA purification and tackle a backlog of over 1,300 cases.


Brian Hoey, supervisor of the DNA unit at the Highway Patrol Laboratory, explained: “Recent policy changes, combined with more reliable and accessible technologies for low level DNA samples, have resulted in a 50 % increase in our workload over the last few years. To meet this extra demand, we needed to increase the laboratory’s capacity and it was obvious that we needed to automate our workflow to achieve this. I visited other laboratories where automation had already been implemented, and Tecan’s Freedom EVO platform was clearly the best instrument for our needs. We have now developed a system that does exactly what we need, automating all DNA extraction, quantification and amplification processes; our workstation is working very well, freeing up laboratory space and allowing analysts to open up more evidence and gather samples.”


To find out more on Tecan’s Freedom EVO liquid handling platforms, visit www.tecan.com/freedomevo




For more information about Tecan, please contact:

Tecan Group Ltd
Cornelia Kegele
Seestrasse 103
CH-8708 Männedorf

T +41 44 922 81 11
F +41 44 922 81 12




About Tecan

Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of automation solutions for laboratories in the life sciences sector. With its subsidiary REMP (www.remp.com), Tecan is the market leader in automated laboratory storage and logistics systems. Its clients include pharmaceutical and biotechnology companies, university research departments and diagnostic laboratories. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2008, Tecan generated sales of CHF 396 million (USD 366.7 million; EUR 250.7 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Swiss security number: 1210019).